Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology
Market Cap
$4.32 Billion
CN¥31.72 Billion CNY
Market Cap Rank
#4923 Global
#571 in China
Share Price
CN¥16.04
Change (1 day)
-0.43%
52-Week Range
CN¥15.58 - CN¥23.17
All Time High
CN¥74.24
About

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamin… Read more

Beijing Tiantan Biological Products Corp Ltd (600161) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.021x

Based on the latest financial reports, Beijing Tiantan Biological Products Corp Ltd (600161) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥318.80 Million) by net assets (CN¥14.95 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Tiantan Biological Products Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Beijing Tiantan Biological Products Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Beijing Tiantan Biological Products Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Tiantan Biological Products Corp Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Beijing Tiantan Biological Products Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥14.53 Billion CN¥819.78 Million 0.056x -69.94%
2023-12-31 CN¥12.75 Billion CN¥2.39 Billion 0.188x +89.27%
2022-12-31 CN¥11.36 Billion CN¥1.13 Billion 0.099x +3.84%
2021-12-31 CN¥10.27 Billion CN¥980.35 Million 0.095x -17.98%
2020-12-31 CN¥6.03 Billion CN¥702.11 Million 0.116x -6.18%
2019-12-31 CN¥5.18 Billion CN¥642.47 Million 0.124x -20.43%
2018-12-31 CN¥4.35 Billion CN¥677.92 Million 0.156x +127.40%
2017-12-31 CN¥3.18 Billion CN¥218.39 Million 0.069x -60.92%
2016-12-31 CN¥2.44 Billion CN¥428.37 Million 0.175x -17.08%
2015-12-31 CN¥2.24 Billion CN¥473.26 Million 0.212x -1.81%
2014-12-31 CN¥2.22 Billion CN¥477.95 Million 0.216x -17.19%
2013-12-31 CN¥2.18 Billion CN¥566.43 Million 0.260x +7.07%
2012-12-31 CN¥1.78 Billion CN¥432.00 Million 0.243x -0.46%
2011-12-31 CN¥1.45 Billion CN¥353.15 Million 0.244x +50.88%
2010-12-31 CN¥1.14 Billion CN¥184.85 Million 0.162x -65.73%
2009-12-31 CN¥949.13 Million CN¥448.23 Million 0.472x +29.34%
2008-12-31 CN¥756.97 Million CN¥276.39 Million 0.365x +72.54%
2007-12-31 CN¥725.57 Million CN¥153.55 Million 0.212x -2.89%
2006-12-31 CN¥708.35 Million CN¥154.36 Million 0.218x +10.72%
2005-12-31 CN¥669.09 Million CN¥131.69 Million 0.197x +13.83%
2004-12-31 CN¥636.79 Million CN¥110.11 Million 0.173x +64.78%
2003-12-31 CN¥599.70 Million CN¥62.93 Million 0.105x -64.06%
2002-12-31 CN¥289.04 Million CN¥84.38 Million 0.292x +81.90%
2001-12-31 CN¥289.68 Million CN¥46.49 Million 0.160x -6.46%
2000-12-31 CN¥279.21 Million CN¥47.90 Million 0.172x +12.68%
1999-12-31 CN¥279.67 Million CN¥42.58 Million 0.152x +70.68%
1998-12-31 CN¥265.80 Million CN¥23.71 Million 0.089x --